Navigation and service

EMA moving to Amsterdam – congratulations

The race for the new EU medicines authority is over and a decision has been made: Amsterdam will be the new site of the European Medicines Agency (EMA). The Paul-Ehrlich-Institut (PEI) sends its best wishes to the Netherlands and its congratulations for this special success.

Flag of the European Union (Source: PEI)

"We are very happy to continue to provide our expertise in the field of vaccines and biomedicines since this enables us to support the EMA actively" says Professor Klaus Cichutek, president of the PEI.

It is vital for Europe that the EMA is able to run its daily business for an efficient collaboration of the regulatory authorities. A speedy relocation is an important prerequisite. It guarantees that the EMA is constantly and rapidly available to the experts of the European regulatory authorities.

How do you rate this article

This Page

Additional Information

Further Information

01.11.2016: Collaboration Agreement between the Paul-Ehrlich-Institut and the University of Texas Medical Branch

more

14.10.2016: Collaboration Agreement between the Paul-Ehrlich-Institut and the Mexican Regulatory Authority COFEPRIS

more

27.06.2012: Paul-Ehrlich-Institut (PEI) signs collaboration agreement with Swissmedic

more

19.08.2011: Confidentiality Agreement with Health Canada

more

14.12.2010: Paul-Ehrlich-Institut (PEI) signs Collaboration Agreement with Sister Authority HSA in Singapore

more

12.11.2010: Paul-Ehrlich-Institut (PEI) signs collaboration agreement with the Chinese health authority NICPBP

more

01.04.2010: Visit by the Chinese Sister Authority NICPBP at the Paul-Ehrlich-Institut

more